Additional file 2 of Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma
收藏数据链接:
官方服务:
资源简介:
Additional file 2.
创建时间:
2022-03-16

Additional file 2.